Heat-shock protein 90 inhibitors in cancer therapy: 17AAG and beyond

By Younes Anas   Georgakis Georgios V  

Future Oncology, Vol. 1, Iss. 2, 2005-04 ,pp. : 273-281

Future Medicine

Access to resources Recommend Favorite

Heat-shock protein expression in leukemia

By Sedlackova Lucie  

Tumor Biology, Vol. 32, Iss. 1, 2011-02 ,pp. : 33-44

Springer Publishing Company

Access to resources Recommend Favorite

Heat Shock Protein 90 Inhibitors as Therapeutic Agents

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 3, 2012-09 ,pp. : 313-336

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of a heat shock protein 90specific inhibitor on the proliferation and apoptosis induced by VEGFC in cervical cancer cells

By        

Experimental and Therapeutic Medicine, Vol. 8, Iss. 5, 2014-01 ,pp. : 1559-1564

Spandidos Publications

Access to resources Recommend Favorite

Heat shock protein 27: a potential biomarker of peritoneal metastasis in epithelial ovarian cancer?

By Zhao M.   Ding J.   Zeng K.   Zhao J.   Shen F.   Yin Y.   Chen Q.  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1051-1056

Springer Publishing Company

Access to resources Recommend Favorite